Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Cox Carrie Smith. Director active across 7 companies, notably CARDINAL HEALTH INC. Cumulatively, 19 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €712k. Activity tracked since 11 November 2021. The latest transaction was disclosed on 13 May 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Cox Carrie Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
COX CARRIE SMITH has 19 filings in total. In the 19 most recent filings available, buy amounts stand at EUR 711613, sell amounts at EUR 0, and the period runs from 2016-02-01 to 2026-05-14. She is Director at Texas Instruments INC, Solventum Corp, Cartesian Therapeutics, Inc., CARDINAL HEALTH INC and Selecta Biosciences INC, and Executive Chair at Organon & Co.; the main recent filings concern Texas Instruments INC, Organon & Co., and Selecta Biosciences INC.